Archive for the ‘Qui Tam Litigation’ Category

Watchdog Group Blows Whistle On Guitar Hero Brands

A qui tam case filed in the Texas Northern District Court by a patent watchdog group (The Patent Compliance Group, the PCG) against Activision Video Game Products, the firm that owns the Guitar Hero line of video games and video game products, accuses the company of patent law infringement.

The lawsuit accuses the Activision brand of improperly labeling its products with the patent and patent-pending notation used to protect brand names from copyright infringement. The case involves provision 35 U.S.C. 292(a) which establishes that, “”… whoever marks upon, or affixes to, or uses in advertising in connection with any article the words “patent applied for,” “patent pending,” or any word importing that an application for patent has been made, when no application for patent has been made, or if made, is not pending, for the purpose of deceiving the public - Shall be fined not more than US$500 for every such offense (in this case per item sold).”

Even though Activision does have some patents currently pending, PCG claims that the patents the company has filed do not cover the scope the packaging notation has claimed.

Posted in False Certifications, False Claims, Qui Tam Information & Articles, Qui Tam LitigationNo Comments

Qui Tam Lawsuit Over Inferior PVC Pipe

A Qui Tam suit has been brought against J-M Manufacturing Co and Formosa Plastics Corp, the manufacturing company’s previous parent company. Four states, twenty-one water districts and twenty-two cities in California have brought the lawsuit following reports that J-M Manufacturing had been supplying sub-standard PVC pipe.

The suit accuses J-M of taking several “cost-cutting” measures, including producing inferior quality PVC pipe, filling supervisor positions with inexperienced workers and providing independent quality-testers with a higher quality sample of product than what was actually being provided to customers.

For cities using these PVC pipes for water management, inferior quality product means a bad investment in public infrastructure. John Hendrix, who worked as an engineer in the J-M’s product assurance department, blew the whistle on the manufacturing company’s product quality issues and was reportedly fired by the company a week later.

The suit states that Hendrix’s employment was terminated after he wrote a memo to upper management informing them that the tensile strength of the PVC pipe being supplied was below the certification agency standards provided by Underwriters Laboratories, Inc.

Posted in False Certifications, Other Kinds of Fraud, Qui Tam LitigationNo Comments

Announcement of Pfizer’s Off-Label Settlement a Harbinger of Increasing Accountability

Last Wednesday, the Justice Department held a conference to announce Pfizer’s off-label criminal and civil settlement for its fraudulent marketing practices.

Pfizer’s subsidiaries will plead guilty to a felony violation of the Food, Drug and Cosmetic Act for misbranding with the intent to defraud or mislead. It will pay a criminal fine of $1.195 billion and forfeit $105 million, bringing the total criminal settlement to $1.3 billion.

The civil settlement of $1 billion will resolve claims under the False Claims Act that Pfizer illegally promoted four of drugs (most notably the anti-inflammatory drug Bextra), caused false claims to be submitted to government healthcare programs for indications other than those approved by the FDA, and provided kickbacks to doctors to induce them to prescribe these drugs.

Pfizer has also entered into a Corporate Integrity Agreement with the Office of Inspector General of the Department of Health and Human Services that will subject the company’s marketing practices to additional review procedures and safeguards to help avoid and promptly detect similarly offending conduct. For example, Pfizer’s executives will need to complete annual compliance certifications and the company will be required to make detailed disclosures on its website. 

The settlement is notable enough for its sheer magnitude: it is the largest in the Department of Justice’s history; it also represents the largest criminal fine imposed ever in the United States for any matter.

But the story behind the story is also interesting. The settlement itself was already announced–and largely completed–by the Bush administration. But whereas the Bush administration was less likely to tout its strikes against big pharmaceutical companies, the Obama administration is happy to take the credit. This certainly signals a bleak future for the drug companies. The administration appears poised to go after these cases with more gusto, especially as it faces criticism for the high cost of Obama’s healthcare proposals.

In January, Eli Lilly and Company settled similar claims over its marketing of Zyprexa for $800 million. The success of that case can be traced directly to courageous stands taken by employee whistleblowers. 

The six whistleblowers in the Pfizer case will share some $102 million of the federal portion of the civil recovery. As employee whistleblowers continue to work with the current administration, we can expect to see more of these announcements in the coming months.

Posted in Damages, Healthcare Fraud, Off-Label Marketing, Qui Tam Litigation, SettlementsNo Comments

When to Contact a Whistleblower Attorney

Do you know about fraud committed against the Federal or State government? It may be time to call a whistleblower attorney to represent you in court. This article will help you understand the basis for and method of filing a Qui Tam lawsuit or what is better known as a ”Whistleblower” lawsuit against a corporation or medical practice that is defrauding the government.

The False Claims Act (FCA) was originally passed during the Civil War, but was amended in 1986 and gives citizens a potential monetary reward for reporting fraud. Typically, the individual who has reported the fraud is an employee or former employee of the corporation in question. This individual, known as the “relator,” is the whistleblower.

Once the “whistle is blown” as it were, the Department of Justice will review the case and decide whether or not it wants to intervene. Since the 1986 amendments, whistleblower attorneys have been able to recover over $12 Billion.

You will want to contact a whistleblower attorney for healthcare fraud (Medicare, Medicaid, drug corporation) or other government contracting frauds. A good attorney can represent your case and help you learn the details of being a relator in the case.

Turning a corporation in for fraud does not need to be a daunting process with the help of an experienced whistleblower attorney. It can be financially beneficial to you as the relator, and is also of beneficial to your country. If you suspect fraud and are interested in filing a claim, don’t hesitate to contact a whistleblower attorney.

Posted in Federal False Claims Act, Other Kinds of Fraud, Qui Tam Information & Articles, Qui Tam LitigationNo Comments

This blog is designed to provide general information only. This information is not and should not be construed to be legal advice. The transmission of the information found on this blog also does not result in the formation of a lawyer-client relationship.

Copyright 2010 Berg & Androphy.